drugset / Trial / NCT07698613
EGFR Targeted Photoimmunotherapy With ASP-1929 for Locally Advanced Pancreatic Cancer
Phase 1/2
Not yet recruiting
30 enrolled
Brown University
Rakuten Medical, Inc. · collabRhode Island Hospital · collabThe Miriam Hospital · collab
NaSingle-groupOpen-labelTreatment
Summary
This is an open label phase II study to determine the safety and preliminary efficacy of photoimmunotherapy (PIT) for patients with locally advanced and borderline resectable pancreatic cancer.
Timeline
- Start
- 2026-09
- Primary completion
- 2029-03
- Completion
- 2033-09
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | CETUXIMAB SAROTALOCAN | Other / unclassified | — | Intravenous |